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Background and purpose   The first generations of total ankle 
replacements (TARs) showed a high rate of early failure. In the 
last decades, much progress has been made in the development of 
TARs, with the newer generation showing better results. We eval-
uated TARs implanted with rheumatoid arthritis (RA) or juvenile 
inflammatory arthritis (JIA) as indication. 
Patients  and  methods      58  total  ankle  prostheses  (Buechel-
Pappas and STAR type) were implanted in patients with RA (n = 
53) or JIA (n = 5) in 54 patients (4 bilateral). After a mean follow-
up of 2.7 (1–9) years, all patients were reviewed by two ortho-
pedic surgeons who were not the surgeons who performed the 
operation. Standard AP and lateral radiographs were taken and 
a Kofoed ankle score was obtained; this is a clinical score rang-
ing from 0–100 and consists of sub-scores for pain, disability, and 
range of motion. 
Results   2 patients died of unrelated causes. Of the 52 patients 
who were alive (56 prostheses), 51 implants were still in place and 
showed no signs of loosening on the most recent radiographs. The 
mean Kofoed score at follow-up was 73 points (SD 16, range 21–
92). 4 patients showed a poor result (score < 50) with persistent 
pain for which no obvious reason could be found. 5 implants were 
removed, 4 because of infection and 1 because of aseptic loosen-
ing.
Interpretation   Medium-term results of the STAR and BP types 
of TAR in RA were satisfactory. The main reason for failure of the 
implant was infection. 

 
The  standard  treatment  for  end-stage  arthritis  of  the  ankle 
joint  due  to  rheumatoid  arthritis  (RA)  has  been  an  ankle 
fusion. In the last decades, much progress has been made in 
the development of total ankle replacements (TARs). Most 
TARs are implanted in patients with RA and posttraumatic 
arthritis. The first generations of TARs were implants with 2 
parts, one inserted in the distal tibia and one placed on top of 
the talus. These implants showed a high rate of early failure, 
especially early loosening. The current TARs consist of three 
components, a metal implant placed in the distal tibia, a metal 
component in the talus, and a polyethylene insert in-between. 
These implants allow a certain amount of gliding and rotation, 
whereas the previous more constrained prostheses behaved as 
a hinge. 
This study was undertaken to evaluate all TARs implanted 
at our centers in patients with RA or juvenile inflammatory 
arthritis (JIA) as indication. 
Patients and methods 
Patient characteristics (Figure 1)
Between  1996  and  2004,  58  total  ankle  prostheses  were 
implanted in 54 patients with RA or JIA (53 and 5 TARs, 
respectively; 4 bilateral) at the Radboud University Nijmegen 
Medical Center and Sint Maartenskliniek, both in Nijmegen, 
the Netherlands. 48 implants were placed in women, and 10 in 
men. Mean age at the time of operation was 55 (27–82) years. 
All patients were operated by experienced senior orthopedic 
surgeons (JWL, MdWM) using the same technique.
 
Types of implants and surgical technique 
Two different implants were used, both consisting of 2 metal 
components and a polyethylene bearing. One surgeon (JWL) 
always  used  the  Scandinavian-Type  Ankle  Replacement 
(STAR, Waldemar Link, Hamburg, Germany) (n = 29), while 
the other surgeon (MdWM) used the same implant for 3 years 
(n = 8); the rest of the implants were Buechel-Pappas type 
(BP; Endotec, South Orange, NJ) (n = 21) (Figure 2).
After  antibiotic  prophylaxis  (1  gram  Cefazolin  i.v.)  and 
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After mobilization of the neurovascular bundle to the lateral 
side, the joint was opened and the synovium excised. The 
bony surfaces of the distal tibia and the talus were prepared 
for placement of the 2 metal components, whereafter the poly-
ethylene bearing was inserted in-between. The wound was 
closed over a suction drain, which was removed on the second 
postoperative day. After the postoperative swelling had dimin-
ished, a lower leg cast was applied. Antithrombotic prophy-
laxis was by means of 0.3 mL nadroparin subcutaneously for 
6 weeks. Patients started weight bearing after 2 weeks, when a 
walking cast was applied. After 4 weeks, the cast was removed 
and patients could start to ambulate as tolerated and to practice 
movement of the artificial joint. Normally, physiotherapy was 
not needed. 
Outcome measures
After a mean follow-up of 2.7 (1–9) years, all patients were 
The remaining 14 fractures healed uneventfully. 3 patients had 
early surgical site infections that were treated by exploration 
of the surgical site and debridement of the wound, and sys-
temic and local antibiotics. 2 early infections were treated suc-
cessfully. In the other patient, the implant had to be removed 
and an ankle fusion was performed. 
Two chronic infections occurred, the first was the above-
mentioned patient with a wound-healing problem over a frac-
ture. Initially, the wound appeared to heal well but after a 
few weeks the patient developed a deep infection, which was 
treated by removal of the implant and fusion of the ankle, 6 
months after the index operation. Another late infection was 
seen 4 years after implantation of the TAR; this patient had an 
ipsilateral infected total knee replacement. Both the infected 
knee prosthesis and the TAR could not be treated adequately 
with antibiotics and several surgical debridements, and she 
underwent an above-knee amputation.
Figure 1. Severe degenerative changes.
Figure 2. A Buechel-Pappas type ankle 
prosthesis in situ.
reviewed  by  2  orthopedic  surgeons  who  were 
not the surgeons who performed the operation. 
Standard AP and lateral radiographs were taken 
and a Kofoed score was obtained. We analyzed 
2 forms of failure: firstly, the traditional failure 
rate consisting of removal of the prosthesis or 
amputation. The  second  endpoint  was  defined 
as removal of the prosthesis for any reason or a 
clinical score below 50.
 
Results
Complications
During implantation of the prostheses, 10 cases 
sustained a medial malleolar fracture, 3 a lateral 
malleolar fracture, and in 3 patients a fracture of 
the posterior part of the tibial plafond occurred. 
The occurrence of a fracture was unrelated to 
the  type  of  implant  used,  the  surgeon,  or  the 
total number of implants the surgeon had placed 
before. The posterior tibial plafond fractures and 
6 medial malleolar fractures were treated with 
the normal aftercare (6 weeks with below-knee 
walking  cast)  and  healed  uneventfully.  The  3 
lateral  malleolar  fractures  and  the  remaining 
medial fractures were treated with reduction and 
internal fixation (malleolar screw on the medial 
side; lag screw and neutralization plate on the 
lateral side).
One implant became infected after a wound-
healing problem over a medial malleolar fracture, 
which had been treated with osteosynthesis. This 
implant was removed and the ankle was fused 
6  months  after  the  index  operation.  Another 
implant  lost  its  tibial  fixation  and  had  to  be 
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One STAR talar component showed symptomatic migration 
and was removed after 4.2 years, and the ankle was subse-
quently fused. 
A summary of all complications is given in Table 1.
Outcome
2 patients died of an unrelated cause 4 and 4.3 years after uni-
lateral TAR operations; at the last follow-up there had been no 
radiographic signs of loosening.
 In the 52 patients who were alive at the latest follow-up 
(56 prostheses), 51 implants were still in place after a mean 
follow-up of 2.7 (1–9) years. The mean Kofoed ankle score 
at follow-up was 73 points (SD 16, range 21–92). 4 patients 
showed a poor result (with a Kofoed score of < 50). These 4 
patients all had persistent pain, for which no obvious reason 
could be found (Table 2). 
With removal of the implant as endpoint, the success rate 
was  over  92%  (Figure  3).  Taking  clinical  failure  (Kofoed 
score < 50) into account, the success rate was 88%. A logis-
tic regression analysis with implant failure as dependent vari-
able  showed  that  infection  was  the  most  important  factor 
(p < 0.001). Type of implant (p = 0.08), surgeon (p = 0.4), 
peroperative fracture (p = 0.6), side operated (p = 0.7), and sex 
(p = 0.3) did not reach statistical significance. Logistic regres-
sion analysis with implant failure or a clinical score below 50 
as endpoint showed the same results: infection was the only 
significant predictive factor (p < 0.01); type of implant (p = 
0.08), surgeon (p = 0.8), peroperative fracture (p = 0.2), side 
operated (p = 0.6), and sex (p = 0.08) were not significant.
 The relative risk (RR) of implant failure with or without 
infection was 15 (CI: 2–45). The RR of failure with or without 
a perioperative fracture was 1.66 (CI: 0.3–9). 
Discussion
Total ankle replacement in RA showed good medium-term 
results in our series, similar to those in a recently published 
meta-analysis (Stengel et al. 2005). Early and especially late 
infection of the prosthesis is a major threat. The high incidence 
of peroperative fractures did not influence the outcome. It is 
important to recognize that complications such as peropera-
tive fracture do not necessarily lead to a poor outcome; on the 
other hand, the absence of complications or radiographic find-
ings does not guarantee a good clinical result. In many studies 
regarding the medium- or long-term results of endoprostheses, 
the endpoint has been revision for any reason. Failure may 
also be defined as patient dissatisfaction with the result of the 
procedure, regardless of the symptoms or physical findings 
(Hasan et al. 2002).
Rheumatoid  arthritis  frequently  involves  the  hindfoot 
(Michelson et al. 1994, Klenerman 1995, Cracchiolo 1997). 
Unfortunately, this part of the foot is often overlooked when 
caring for these patients—who often have multiple areas of 
involvement giving pain and producing deformity. Early treat-
ment consists of proper or custom-made footwear and occa-
sional injections of corticosteroids (Cracchiolo 1997). Early 
synovectomy may be valuable, but it is controversial whether 
a synovectomy can halt the progression of joint destruction 
(Akagi et al. 1997, Nakamura et al. 2004). Ankle fusion is a 
well-established operation with few complications and good 
pain relief, and improvement in walking ability (Maenpaa et 
al. 2001, Panotopoulos et al. 2005, Winson et al. 2005). 
With an arthrodesis of the talotibial joint, the normal func-
tion of the hindfoot is altered. This results in altered walking 
kinematics—especially an earlier heel-off—and this becomes 
worse when walking barefoot or with increased speed (Bey-
aert et al. 2004). The loss of ankle motion caused by an ankle 
Figure 3. Kaplan-Meier survival curve with removal of the prosthesis 
as outcome measure. The green line represents the BP prosthesis, the 
blue line the STAR.
Table 1. Summary of complications and outcome
Complication a   Resulted in failure (5)   Implant in situ (51)
Peroperative fracture   2   14
Early infection   1   2
Late infection   2   0
No perioperative 
  complications   1   35
a One patient had both an infection and a fracture.
Table 2. Results in relation to the type of implant used
  STAR (n = 37)   BP (n = 21)
Poor clinical result
(Kofoed score < 50)     4     0
Removal of implant     4      1 
Implant in situ and Kofoed > 50   29    20 
Mean (range) follow-up in years     2.4 (0.5–6.5)     3.3 (0.5–9)
Died from unrelated cause     2     0Acta Orthopaedica 2009; 80 (4): 440–444  443
fusion increases strain on the adjacent joints of the ipsilateral 
foot, and many patients develop degenerative changes in the 
subtalar and midtarsal joints (Mazur et al. 1979, Muir et al. 
2002). It is important to know that in the literature prior to 
1979, the results obtained with ankle arthrodesis were gen-
erally graded as good if arthrodesis was achieved or poor if 
nonunion resulted, so the result “good” or “poor” was only 
based on the radiograph; the clinical result was not taken into 
account (Abidi et al. 2000).
  The  advantages  of  total  ankle  replacement  over  ankle 
arthrodesis include preservation of motion and reduced stresses 
on the midfoot and subtalar joints (Su et al. 2004). Especially 
patients with rheumatoid arthritis may already have subtalar 
degeneration when they present with ankle pain, making ankle 
arthrodesis a less appealing treatment. Secondary procedures 
to the foot, and especially the subtalar joint, are often part of 
the surgical plan and are performed either before or simultane-
ously with ankle replacement (Greisberg et al. 2004).
The early TAR design components were highly constrained; 
these implants showed an unacceptable rate of loosening—
as high as 50% within a few years (Dini and Bassett 1980, 
Newton 1982, Helm and Stevens 1986). This high failure rate 
is probably due to the greater stress at the bone-prosthesis 
interface, as constrained implants do not allow rotation and 
sliding during extension and flexion (Conti and Wong 2001). 
The  current  generation  of  implants,  consisting  of  3  com-
ponents  including  a  mobile  polyethylene  bearing,  shows  a 
lower loosening rate after medium-term follow-up (Buechel 
and Pappas 1992, Kofoed and Sorensen 1998, Kofoed and 
Lundberg-Jensen  1999,  Buechel  et  al.  2002,  Anderson  et 
al. 2003, Buechel et al. 2003, Kofoed 2004, Su et al. 2004, 
Doets et al. 2006, San Giovanni et al. 2006). Both implants 
used in our series are well documented. The STAR prosthesis 
has shown comparable results in other studies (Kofoed and 
Sorensen 1998, Kofoed and Lundberg-Jensen 1999, Anderson 
et al. 2003, Wood and Deakin 2003, Kofoed 2004), as has the 
Buechel-Pappas type (Buechel and Pappas 1992, Buechel et 
al. 2002, Buechel et al. 2003, Su et al. 2004, Doets et al. 2006, 
San Giovanni et al. 2006). Most studies regarding the results 
of implants have been from the institute of the designer of the 
implant. The experience of these individuals, while valuable, 
is not necessarily representative of the experience of orthope-
dic surgeons in general. Furthermore, in most outcome studies 
different indications are included; in our study only RA and 
JIA patients were included.
In a radiostereometric analysis of the tibial component of 
the Buechel-Pappas type of implant, a migration of the tibial 
component of 0.9 mm was observed during the first 3 months, 
but this stabilized by the 6-month follow-up (Nelissen et al. 
2006). We are not aware of any reports regarding the initial 
stability  of  the  talar  component  of  the  BP  prosthesis.  For 
the STAR type, a similar migration pattern was found: some 
migration during the initial postoperative period but little or 
no migration after 6 weeks (Carlsson et al. 2005).
Although complications are commonly described and the 
surgery is technically demanding (Greisberg et al. 2004), in 
experienced hands and with a good indication, this kind of 
surgery may yield good results. However, a suboptimal place-
ment of the prosthesis will lead to early failure (Greisberg et 
al. 2004). The results for patients with degeneration due to 
osteoarthritis do not differ from those suffering from rheuma-
toid arthritis (Kofoed and Sorensen 1998); furthermore, age 
does not seem to affect the outcome (Kofoed and Lundberg-
Jensen 1999). 
Compared to a standard ankle fusion, ankle fusion after a 
failed arthroplasty more often results in a non-union (Hop-
good et al. 2006, Kotnis et al. 2006). In our group, 2 patients 
showed a delayed union—for which a new intervention was 
necessary, but all fusions united. Although the function of a 
total ankle prosthesis is never the same as a normal ankle joint 
and clinical results are sometimes poor when looking at a sub-
jective score, patient satisfaction is higher than expected from 
these scores (Nishikawa et al. 2004).
 
Study design: HH and JWL; review of patients: HH and BS; data analysis 
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